medical cure for HIV/AIDS.
A research team at the Michael Okpara University of Agriculture,
Umudike (MOUAU), Abia State led by Prof. Maduike Ezeibe has been able to
prove that Medicinal Synthetic Aluminium-magnesium Silicate (MSAMS),
which it developed, can cure HIV/AIDS.
The result of the clinical trial of the antiretroviral efficacy of
MSAMS in male and female HIV/AIDS patients was published in the British
Journal of Medicine & Medical Research 18 (11):1-7, 2016; Article no
BJMMR.29018.
It was also among the papers presented last Wednesday at the World
Virology Conference 2016 held at Texas, U.S. Though Ezeibe could not
attend the conference because of his inability to raise money for his
flight tickets, the organisers insisted that he sent a video
presentation, which was played and applauded at the conference.
Speaking with journalists at the weekend on the apparent lukewarm
attitude of Nigeria’s health authorities to his medical breakthrough,
the professor of Veterinary Medicine said that since 2014 when he was
issued with the national patent right (Ref. No. NG/P/2012/639, 2014) no
further step had been taken to commercialise it or get the international
patent right by Nigeria.
“We Africans lack confidence in ourselves,” he lamented,
adding that the medicine that he had discovered to have antiretroviral
properties is an old medicine which had been in use.
“The only science we did is that we discovered that it has
charges – negative and positive and since HIV has positive charges, the
MSAMS use its negative charges to attract and destroy HIV,” he said.
He said that HIV/AIDS had remained incurable because of the small
size of the virus and immune deficiency it causes hence any
anti-retroviral medicine that could effectively tackle the problem must
be smaller (nano-particles).
According to him, particles of HIV could be as small as 110nm which
was why they easily crossed physiological barriers to ‘hide’ in cells
of the brain, bone marrow and testes, which existing antiretroviral
medicines with bigger molecules could not reach.
Ezeibe explained: “HIV destroys lymphocytes (immune cells that
clear infections from organs that are inaccessible to medicines. So,
nothing was known that could terminate its infections (and) for that the
infection was said to be in ‘sanctuary’.”
The professor reasoned that since Aluminum-magnesium Silicate (AMS)
molecular platelets (nanoparticles) are smaller (0.96nm) than HIV, the
nanoparticles cross physiological barriers to act on all body cells.
But the snag was that AMS is not found as mineral deposits in
Nigeria whereas there are large deposits of Aluminum silicate and
magnesium silicate in the country both of which are used as medicines
for treatment of animal and human diseases.
So in order to get a purer form of AMS, Ezeibe reacted the two
medicinal minerals (Aluminum silicate and magnesium silicate) and the
Aluminum magnesium silicate was born, the synthetic medicine that has
now been proved to cure HIV/AIDS.
“We are using medicine that is so small that wherever HIV goes it can get there, catch it and destroy it,” he assured.
The efficacy of Ezeibe’s synthetic medicine is already generating
interest among medical doctors and those that were involved in the
clinical trial have already joined his research team after using the
drug to treat their patients with astonishing results.
Interestingly, on the day Ezekiel’s research breakthrough was being
presented at the world Virology Conference in Texas, he was also making
a presentation before the Senate of MOUAU.
It is now expected that the university authorities would take up
the advocacy to recognise and commercialise this important breakthrough
in medical science by a Nigerian.
Culled from Reports Afrique
No comments:
Post a Comment